Oxycodone hydrochloride and Cisplatin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Oxycodone hydrochloride (oxycodone hydrochloride) and Cisplatin (cisplatin). Common drug interactions include death among females and abdominal pain among males.
The phase IV clinical study analyzes what interactions people have when they take Oxycodone hydrochloride and Cisplatin. It is created by eHealthMe based on reports of 83 people who take the same drugs from the FDA, and is updated regularly.
What is Oxycodone hydrochloride?
Oxycodone hydrochloride has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 36,817 Oxycodone hydrochloride users. Check the latest studies of Oxycodone hydrochloride.
What is Cisplatin?
Cisplatin has active ingredients of cisplatin. It is often used in chemotherapy. eHealthMe is studying from 92,837 Cisplatin users. Check the latest studies of Cisplatin.
83 people who take Oxycodone hydrochloride and Cisplatin together, and have interactions are studied.

What are the common drug interactions of Oxycodone Hydrochloride and Cisplatin, by gender? *:
female:
- Death
- Dehydration (dryness resulting from the removal of water)
- Drug ineffective
- Electrolyte imbalance
- Emotional distress
- Foot fracture
- Hip fracture
- Hypokalaemia (low potassium)
- Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
- Multiple fractures
male:
- Abdominal pain
- Blood lactate dehydrogenase increased
- Rash erythematous (redness of the skin)
- White blood cell count decreased
- Death
- Decreased appetite
- Delirium (wild excitement)
- Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Pneumonia fungal
What are the common drug interactions of Oxycodone Hydrochloride and Cisplatin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Bacterial sepsis
- Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
- Enterococcal sepsis
- Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
20-29:
n/a
30-39:
- Colitis (inflammation of colon)
- Gastritis (inflammation of stomach)
- Liver disorder (liver diseases)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Poisoning
- Stomatitis (inflammation of mucous membrane of mouth)
40-49:
- Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
- Disseminated intravascular coagulation (systemic activation of blood coagulation)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Myelitis transverse (a neurological condition consisting of an inflammatory process of the spinal cord)
- Rash erythematous (redness of the skin)
- Bacterial sepsis
- Febrile neutropenia (fever with reduced white blood cells)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Addison's disease (addison's disease, a hormonal disorder disease)
- Renal impairment (severely reduced kidney function)
50-59:
- Pyrexia (fever)
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Sinusitis (inflammation of sinus)
- Abdominal pain
- Blood lactate dehydrogenase increased
- Abdominal neoplasm (cancer of the stomach)
- Disease progression
- Neoplasm (tumour)
- Delirium (wild excitement)
- Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
60+:
- Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
- Death
- White blood cell count decreased
- Decreased appetite
- Hyperglycaemia (high blood sugar)
- Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
- Pneumonia fungal
- Blood alkaline phosphatase increased
- Chronic kidney disease
What are the existing conditions these people have? *
- Nausea (feeling of having an urge to vomit): 20 people, 24.10%
- Constipation: 14 people, 16.87%
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 11 people, 13.25%
- Lung Cancer - Non-Small Cell (lung cancer): 10 people, 12.05%
- Hyperlipidaemia (presence of excess lipids in the blood): 9 people, 10.84%
- Fever: 9 people, 10.84%
- Insomnia (sleeplessness): 8 people, 9.64%
- Oesophageal Cancer Metastatic (cancer of oesophagues spreads to other part): 7 people, 8.43%
- Stress And Anxiety: 6 people, 7.23%
- Neoplasm Malignant (cancer tumour): 6 people, 7.23%
* Approximation only. Some reports may have incomplete information.
Do you take Oxycodone hydrochloride and Cisplatin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Oxycodone hydrochloride (36,817 reports)
- Cisplatin (92,837 reports)
Browse all drug interactions of Oxycodone hydrochloride and Cisplatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Oxycodone hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cisplatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Oxycodone hydrochloride and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cisplatin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .
- Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on oxycodone hydrochloride and cisplatin (the active ingredients of Oxycodone hydrochloride and Cisplatin, respectively), and Oxycodone hydrochloride and Cisplatin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Dramamine cause Gastroesophageal Reflux Disease? - 2 seconds ago
- Could Linzess cause Electrolyte Imbalance? - 2 seconds ago
- Drug interactions of Prednisone and Arcapta Neohaler - 6 seconds ago
- Could Sanctura cause Headache? - 12 seconds ago
- Precocious Puberty and Drug Ineffective - 21 seconds ago
- Drug interactions of Cymbalta and Zetia - 28 seconds ago
- Drug interactions of Rapaflo and Guaifenesin - 30 seconds ago
- Drug interactions of Tirosint and Cetirizine Hydrochloride - 31 seconds ago
- Could Ezetimibe cause Fluid Retention? - 38 seconds ago
- Drug interactions of Zetia and Donepezil - 38 seconds ago